[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Halozyme Therapeutic (HALO)

Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Halozyme to Participate at Upcoming Investor Conferences

SAN DIEGO , Sept. 2, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, and Darren Snellgrove,...

HALO : 109.16 (+1.34%)
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid

1 Mid-Cap Stock on Our Watchlist and 2 We Avoid

DCI : 90.18 (+0.47%)
VRSK : 189.06 (-2.72%)
HALO : 109.16 (+1.34%)
3 Market-Beating Stocks for Long-Term Investors

3 Market-Beating Stocks for Long-Term Investors

EVR : 288.19 (+0.68%)
CW : 562.10 (-2.75%)
HALO : 109.16 (+1.34%)
1 Healthcare Stock with Exciting Potential and 2 We Avoid

1 Healthcare Stock with Exciting Potential and 2 We Avoid

EHC : 121.40 (-0.53%)
WST : 341.79 (+0.93%)
HALO : 109.16 (+1.34%)
2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges

2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges

BURL : 259.55 (-0.99%)
XPO : 185.38 (+0.16%)
HALO : 109.16 (+1.34%)
Halozyme Appoints Dannielle Appelhans to its Board of Directors

SAN DIEGO , Aug. 18, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced the election of Dannielle Appelhans to its Board of Directors. Ms. Appelhans brings...

HALO : 109.16 (+1.34%)
The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call

The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call

HALO : 109.16 (+1.34%)
HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance

HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance

HALO : 109.16 (+1.34%)
Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know

Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know

HALO : 109.16 (+1.34%)
1 Profitable Stock to Research Further and 2 We Ignore

1 Profitable Stock to Research Further and 2 We Ignore

MTN : 137.04 (+3.51%)
TTI : 6.55 (+0.31%)
HALO : 109.16 (+1.34%)

Barchart Exclusives

Dear AeroVironment Stock Fans, Mark Your Calendars for September 9
AeroVironment’s upcoming Q1 results are expected to offer investors fresh clues on demand, execution, growth, and profitability. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.